FDA Guidance for Industry: Considerations for Complying With 21 CFR 211.110
Titel:
FDA Guidance for Industry: Considerations for Complying With 21 CFR 211.110
Internet:
Herkunft/Verlag:
FDA
Inhalt:
This guidance, when finalized, will describe considerations for complying with the requirements in 21 CFR 211.110 to ensure batch uniformity and drug product integrity